• Antimicrobial resistance? You’ll know in 2.5 hours.

  • Preventing infection outbreaks saves lifes.

  • Save costs by faster treatment and less isolation.

123

Now you can identify AMR fast and accurate

Carbapenemase producing organisms have spread globally and top the priority list of the World Health Organization as the critical AMR (antimicrobial resistance) threat. It is essential to diagnose carbapenemase resistance as fast and accurate as possible in order to control further spread.

Check-Points has developed accurate molecular assays for rapid detection of carbapenemase and ESBL resistance. These assays deliver fast results – within 2.5 hours – with very high negative predictive value and specific genotypic information on the resistance mechanism.

This saves lives, costs and protects the reputation of your hospital, so you can be confident to stay in control of AMR.

More cost effective than you may think

Swift and accurate results provide benefits to your hospital and your patients.

The costs of healthcare for patients with resistant infections is much higher than care for patients with non-resistant infections, due to longer duration of illness, isolation requirements, additional tests and use of more expensive drugs.

The benefits of rapid AMR surveillance can easily outweigh additional screening costs, due to

  • fast patient release from pre-emptive isolation;
  • fast reopening of blocked wards;
  • reduction of excess costs caused by CPO infections, by lowering hospital transmission.

Fast diagnosis of AMR prevents infection outbreaks, reduces costs and saves lives.

Technology

Check-Points is a pioneer in innovative DNA testing methods in the industry and health sector since its foundation in 2002. Deoxyribonucleic acid, short for DNA, is a molecule that carries the genetic instructions used in the growth, development, functioning and reproduction of all known living organisms and many viruses.

Check-Points has used the specific characteristics of DNA to develop molecular assays to detect beta-lactam resistance in the form of carbapenemases, ESBLs and AmpCs within Enterobacteriaceae.

Check-Points’ innovation by DNA helps to fight serious health problems like Antimicrobial Resistance (AMR) and  Salmonella.

Contact

Check-Points Health 
Binnenhaven 5
6709 PD Wageningen
The Netherlands

+31 (0) 317 453 908
info@check-points.com

Subscribe to our newsletter?